DLDan Liu

Dan Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dan Liu has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • GPCR-Gα13 signaling regulates survival of intestinal intraepithelial CD8+ lymphocytes through migration to cytokine-rich niches

    by Zachary M. Earley, Anshul Rao, Longhui Qiu, Konrad Knöpper, Fanglue Peng, Norihide Jo, Ananya Krishnapura, Wioletta Lisicka, Hanna Taglinao, Jinping An, et al.

  • Open Access

    CXCL13⁺ CD4⁺ T cells are associated with B-cell recruitment and lesion progression in cerebral cavernous malformations

    by Shaozhi Zhao, Yingxi Yang, Ran Huo, Qiuxia Zhou, Hongyuan Xu, Yingfan Sun, Hui Wang, Yang Ni, Yuming Jiao, Jiguang Wang, et al.

    Cerebral cavernous malformations (CCMs) are neurovascular abnormalities associated with lifelong risks of intracranial hemorrhage (ICH), seizures, and neurologic deficits, affecting approximately 0.16%~0.8% of the general population. Although immune cell infiltration is well recognized as promoting CCM progression, the mechanisms underlying their recruitment into the lesion microenvironment remain poorly understood. In our study, we employed single-cell RNA sequencing (scRNA-seq) to identify a significant enrichment of a CD4⁺ T-cell subset producing CXCL13 and decipher the cellular crosstalk within CCMs. The CXCL13-producing CD4⁺ T cells exhibited enhanced interaction with CXCR5⁺ memory B cells, which showed upregulation of genes related to activation, persistence, and targeted migration. Immunohistochemical staining supported the spatial co-localization between CXCL13⁺ CD4⁺ T cells and CXCR5⁺ CD20⁺ B cells, as well as a positive association between their abundances, reinforcing this cellular crosstalk and suggesting a potential role for CXCL13 in shaping the inflammatory microenvironment and local adaptive immune responses. Clinically, elevated CXCL13 expression in CCM lesions was associated with a higher frequency of subacute ICH and B-cell infiltration in patients. Finally, in vivo experiments showed that administration of recombinant CXCL13 increased B-cell infiltration and Prussian blue staining-defined lesion bleeding, whereas blockade of CXCL13 attenuated CCM lesion development. Thus, our study identified a potentially pathogenic CXCL13+ CD4+ T-cell subset in CCMs, providing a rationale for targeting CXCL13 signaling in CCMs.

  • Rapid clearance of achiral small-molecule drugs using de novo-designed proteins and their cyclic and mirror-image variants

    by Guilin Chen, Kai Zhao, Mengjiao Li, Yuefei Zhang, Tian Li, Jing Yuan, Lei Lu, Jesús Valdiviezo, Dan Liu, Nicholas F. Polizzi, et al.

    Small-molecule-binding proteins can neutralize toxins and cytotoxic drugs, but their development is hindered by unpredictable in vivo behaviour and the poor immunogenicity of small molecules, which limits antibody-based approaches. Here we present a strategy to engineer de novo-designed proteins for the effective clearance of Food and Drug Administration-approved drugs in healthy mice. As a proof of concept, we designed proteins that bind to the anticoagulant apixaban. Since apixaban lacks chirality, we used mirror-image synthesis and cyclization to enhance the designed protein’s in vivo stability. Both protein variants demonstrated effective activity, facilitating the rapid clearance of apixaban within 30 min. To assess the broader applicability of this approach, we extended our analysis to a de novo-designed protein targeting the anticancer drug rucaparib, further confirming its potential for small-molecule clearance. Our study shows that de novo-designed small-molecule-binding proteins can be used as antidotes in vivo, and that computational tools can be integrated with medicinal chemistry strategies for precise pharmacological interventions.


  • Open Access

    Intravital imaging of pulmonary lymphatics in inflammation and metastatic cancer

    by Simon J. Cleary, Longhui Qiu, Yurim Seo, Peter Baluk, Dan Liu, Nina K. Serwas, Catherine A. Taylor, Dongliang Zhang, Jason G. Cyster, Donald M. McDonald, et al.

    Intravital microscopy has enabled the study of immune dynamics in the pulmonary microvasculature, but many key events remain unseen because they occur in deeper lung regions. We therefore developed a technique for stabilized intravital imaging of bronchovascular cuffs and collecting lymphatics surrounding pulmonary veins in mice. Intravital imaging of pulmonary lymphatics revealed ventilation dependence of steady-state lung lymph flow and ventilation-independent lymph flow during inflammation. We imaged the rapid exodus of migratory dendritic cells through lung lymphatics following inflammation and measured effects of pharmacologic and genetic interventions targeting chemokine signaling. Intravital imaging also captured lymphatic immune surveillance of lung-metastatic cancers and lymphatic metastasis of cancer cells. To our knowledge, this is the first imaging of lymph flow and leukocyte migration through intact pulmonary lymphatics. This approach will enable studies of protective and maladaptive processes unfolding within the lungs and in other previously inaccessible locations.


  • Open Access

    Dynamic encounters with red blood cells trigger splenic marginal zone B cell retention and function

    by Dan Liu, Benjamin Y. Winer, Marissa Y. Chou, Hanson Tam, Ying Xu, Jinping An, James M. Gardner, Jason G. Cyster

    Spleen marginal zone (MZ) B cells are important for antibody responses against blood-borne antigens. The signals they use to detect exposure to blood are not well defined. Here, using intravital two-photon microscopy in mice, we observe transient contacts between MZ B cells and red blood cells that are in flow. We show that MZ B cells use adhesion G-protein-coupled receptor ADGRE5 (CD97) for retention in the spleen. CD97 function in MZ B cells depends on its ability to undergo autoproteolytic cleavage and signaling via Gα13 and ARHGEF1. Red blood cell expression of the CD97 ligand CD55 is required for MZ B cell homeostasis. Applying a pulling force on CD97-transfected cells using an optical C-trap and CD55+ beads leads to accumulation of active RhoA and membrane retraction. Finally, we show that CD97 deficiency leads to a reduced T cell-independent IgM response. Thus, our studies provide evidence that MZ B cells use mechanosensing to position in a manner that enhances antibody responses against blood-borne antigens.


  • CD97 promotes spleen dendritic cell homeostasis through the mechanosensing of red blood cells

    by Dan Liu, Lihui Duan, Lauren B. Rodda, Erick Lu, Ying Xu, Jinping An, Longhui Qiu, Fengchun Liu, Mark R. Looney, Zhiyong Yang, et al.

    Dendritic cells (DCs) are crucial for initiating adaptive immune responses. However, the factors that control DC positioning and homeostasis are incompletely understood. We found that type-2 conventional DCs (cDC2s) in the spleen depend on Gα 13 and adhesion G protein–coupled receptor family member-E5 (Adgre5, or CD97) for positioning in blood-exposed locations. CD97 function required its autoproteolytic cleavage. CD55 is a CD97 ligand, and cDC2 interaction with CD55-expressing red blood cells (RBCs) under shear stress conditions caused extraction of the regulatory CD97 N-terminal fragment. Deficiency in CD55-CD97 signaling led to loss of splenic cDC2s into the circulation and defective lymphocyte responses to blood-borne antigens. Thus, CD97 mechanosensing of RBCs establishes a migration and gene expression program that optimizes the antigen capture and presentation functions of splenic cDC2s.